Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-29 4:15 pm Purchase | 13G | PRIME MEDICINE INC PRME | GV 2019 L.P. | 15,062,498 12.2% | 3,200,000 (+26.98%) | View |
| 2024-02-22 9:31 pm Purchase | 13D | PRIME MEDICINE INC PRME | ARCH Venture Fund XII L.P. | 15,472,674 12.9% | 15,472,674 (New Position) | View |
| 2024-02-09 4:09 pm Sale | 13G | PRIME MEDICINE INC PRME | GV 2019 L.P. | 11,862,498 12.2% | -1,422,190 (-10.71%) | View |
| 2024-02-09 09:49 am Purchase | 13G | PRIME MEDICINE INC PRME | FMR LLC | 9,088,150 9.338% | 625,104 (+7.39%) | View |
| 2023-02-13 4:08 pm Purchase | 13G | PRIME MEDICINE INC PRME | ARCH Venture Fund X L.P. | 12,272,674 12.6% | 12,272,674 (New Position) | View |
| 2023-02-10 4:05 pm Purchase | 13G | PRIME MEDICINE INC PRME | GV 2019 L.P. | 13,284,688 13.7% | 13,284,688 (New Position) | View |
| 2023-02-09 08:14 am Purchase | 13G | PRIME MEDICINE INC PRME | FMR LLC | 8,463,046 8.706% | 100 (+0.00%) | View |
| 2023-02-07 4:46 pm Purchase | 13G | PRIME MEDICINE INC PRME | Newpath Partners L.P. | 5,305,679 5.5% | 5,305,679 (New Position) | View |
| 2022-10-26 10:20 am Purchase | 13G | PRIME MEDICINE INC PRME | FMR LLC | 8,462,946 8.84% | 8,462,946 (New Position) | View |